Search Count: 14
 |
Hiv-1 Wild Type Protease With Grl-02519A, With N-(2,5-Dimethylphenyl)-4-(Pyridin-3-Yl)Pyrimidin-2-Amine As P2-P3 Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2023-05-24 Classification: HYDROLASE/INHIBITOR Ligands: Y9R, NA, CL, ACT, GOL, FMT |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-05-24
Ligands: Y9R, NA, CL, ACT, GOL, FMT
 |
Hiv-1 Wild Type Protease With Grl-03419A, With N-(2,5-Dimethylphenyl)-4-(Pyridin-3-Yl)Pyrimidin-2-Amine As P2-P3 Group And 3,5-Difluorophenylmethyl As The P1 Group
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.12 Å Release Date: 2023-05-24 Classification: HYDROLASE/INHIBITOR |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2023-05-24
 |
Hiv-1 Wild Type Protease With Grl-05816A, With C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2-Ligand [Diastereomer 1]
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.13 Å Release Date: 2022-03-02 Classification: ANTIVIRAL PROTEIN/INHIBITOR |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
 |
Hiv-1 Wild Type Protease With Grl-01717A, With C-4 Substituted Cyclohexane-Fused Bis-Tetrahydrofuran (Chf-Thf) Derivatives As P2-Ligand [Diastereomer 2]
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.21 Å Release Date: 2022-03-02 Classification: VIRAL PROTEIN/INHIBITOR |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2022-03-02
 |
Hiv-1 Wild Type Protease With Grl-026-18A, A Crown-Like Tetrahydropyranotetrahydrofuran With A Bridged Methylene Group As A P2 Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.18 Å Release Date: 2020-07-01 Classification: HYDROLASE/HYDROLASE INHIBITOR |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-07-01
 |
Hiv-1 Wild Type Protease With Grl-052-16A, A Tricyclic Cyclohexane Fused Tetrahydrofuranofuran (Chf-Thf) Derivative As The P2 Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2020-05-13 Classification: ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-05-13
 |
Hiv-1 Wild Type Protease With Grl-019-17A, A Tricyclic Cyclohexane Fused Tetrahydrofuranofuran (Chf-Thf) Derivative As The P2 Ligand And A Aminobenzothiazole(Abt)-Based P2'-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2020-05-13 Classification: ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-05-13
 |
Hiv-1 Wild Type Protease With Grl-00819A, With Phenyl-Boronic-Acid As P2'-Ligand And With A 6-5-5-Ring Fused Crown-Like Tetrahydropyranofuran As The P2-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.33 Å Release Date: 2019-10-09 Classification: VIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-10-09
 |
Hiv-1 Wild Type Protease With Grl-03119A, With Phenyl-Boronic-Acid As P2'-Ligand And With A Hexahydro-4H-Furo-Pyran As The P2-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.13 Å Release Date: 2019-10-09 Classification: VIRAL PROTEIN Ligands: B4R, NA, CL, FMT, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2019-10-09
Ligands: B4R, NA, CL, FMT, GOL
 |
Hiv-1 Wild Type Protease With Grl-02815A, A Thiochroman Heterocycle With (S)-Boc-Amine Functionality As The P2 Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2018-10-31 Classification: HYDROLASE, ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-10-31
 |
Hiv-1 Wild Type Protease With Grl-04315A, A Tetrahydronaphthalene Carboxamide With (R)-Boc-Amine And (S)-Hydroxyl Functionalities As The P2 Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.14 Å Release Date: 2018-10-31 Classification: HYDROLASE, ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-10-31
 |
Hiv-1 Wild Type Protease With Grl-03314A, 6-5-5-Ring Fused Umbrella-Like Tetrahydropyranofuran As The P2-Ligand, A Cyclopropylaminobenzothiazole As The P2'-Ligand And 3,5-Difluorophenylmethyl As The P1-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.13 Å Release Date: 2018-05-30 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: GR8, NA, CL, GOL, ACT |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: GR8, NA, CL, GOL, ACT
 |
Hiv-1 Wild Type Protease With Grl-03214A, 6-5-5-Ring Fused Umbrella-Like Tetrahydropyranofuran As The P2-Ligand, A Cyclopropylaminobenzothiazole As The P2'-Ligand And 3,5-Difluorophenylmethyl As The P1-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2018-05-30 Classification: HYDROLASE/HYDROLASE inhibitor |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
 |
Crystal Structure Of Wild-Type Hiv-1 Protease With A Novel Hiv-1 Inhibitor Grl-14213A Of 6-5-5-Ring Fused Crown-Like Tetrahydropyranofuran As The P2-Ligand, A Cyclopropylaminobenzothiazole As The P2'-Ligand And 3,5-Difluorophenylmethyl As The P1-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-02-28 Classification: HYDROLASE/HYDROLASE inhibitor |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-02-28